Tanvex BioPharma, Inc.
6541.TW
Price:
$61.3
Market Cap:
$16.23B
Tanvex BioPharma, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and sale of biosimilar in Taiwan and the United States. The company focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. Its products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Industry
Biotechnology
IPO Date
2015-08-13
Stock Exchange
TAI
Ticker
6541.TW
PE Ratio
[-10.03]
ROE
[-31.36%]
Current Ratio
[2.97]
Dividend Yield
[0%]
Enterprise Value
[16.39B]
Dividend History
The ROE as of December 2025 (TTM) for Tanvex BioPharma, Inc. (6541.TW) is -31.36%
According to Tanvex BioPharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -31.36%. This represents a change of 145.60% compared to the average of -12.77% of the last 4 quarters.
Tanvex BioPharma, Inc. (6541.TW) Historical ROE (quarterly & annually)
How has 6541.TW ROE performed in the past?
The mean historical ROE of Tanvex BioPharma, Inc. over the last ten years is -91.85%. The current -31.36% ROE has changed -65.85% with respect to the historical average. Over the past ten years (40 quarters), 6541.TW's ROE was at its highest in in the September 2025 quarter at -4.56%. The ROE was at its lowest in in the March 2024 quarter at -103.02%.
Average
-91.85%
Median
-66.36%
Minimum
-260.27%
Maximum
-34.83%
Tanvex BioPharma, Inc. (6541.TW) ROE by Quarter and Year
Discovering the peaks and valleys of Tanvex BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 120.68%
Maximum Annual ROE = -34.83%
Minimum Annual Increase = -40.58%
Minimum Annual ROE = -260.27%
| Year | ROE | Change |
|---|---|---|
| 2024 | -154.66% | -40.58% |
| 2023 | -260.27% | 120.68% |
| 2022 | -117.94% | 113.59% |
| 2021 | -55.22% | -31.23% |
| 2020 | -80.29% | 7.01% |
| 2019 | -75.04% | 66.99% |
| 2018 | -44.93% | 19.49% |
| 2017 | -37.60% | 7.97% |
| 2016 | -34.83% | -39.62% |
| 2015 | -57.68% | -28.01% |
Tanvex BioPharma, Inc. (6541.TW) Average ROE
How has 6541.TW ROE performed in the past?
The current ROE of Tanvex BioPharma, Inc. (6541.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-177.62%
5-year avg
-133.68%
10-year avg
-91.85%
Tanvex BioPharma, Inc. (6541.TW) ROE vs. Peers
How is 6541.TW’s ROE compared to its peers?
Tanvex BioPharma, Inc.’s ROE is less than Ever Supreme Bio Technology Co., Ltd (37.36%), greater than Foresee Pharmaceuticals Co., Ltd. (-98.79%), greater than Medigen Vaccine Biologics Corporation (-4.45%), less than Excelsior Medical Co., Ltd. (9.22%), greater than AP Biosciences Inc (-25.56%), less than YungShin Global Holding Corporation (12.49%), less than PharmaEngine, Inc. (32.91%), greater than Acepodia, Inc. (-11.14%), greater than EirGenix Inc. (-8.06%), less than ScinoPharm Taiwan, Ltd. (1.82%),
| Company | ROE | Market cap |
|---|---|---|
| 37.36% | $14.45B | |
| -98.79% | $12.39B | |
| -4.45% | $12.41B | |
| 9.22% | $14.00B | |
| -25.56% | $13.62B | |
| 12.49% | $15.32B | |
| 32.91% | $10.34B | |
| -11.14% | $8.98B | |
| -8.06% | $19.18B | |
| 1.82% | $13.92B |
Build a custom stock screener for Tanvex BioPharma, Inc. (6541.TW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tanvex BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Tanvex BioPharma, Inc. (6541.TW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Tanvex BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Tanvex BioPharma, Inc.'s ROE?
How is the ROE calculated for Tanvex BioPharma, Inc. (6541.TW)?
What is the highest ROE for Tanvex BioPharma, Inc. (6541.TW)?
What is the 3-year average ROE for Tanvex BioPharma, Inc. (6541.TW)?
What is the 5-year average ROE for Tanvex BioPharma, Inc. (6541.TW)?
How does the current ROE for Tanvex BioPharma, Inc. (6541.TW) compare to its historical average?